Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • #16
    Originally posted by lh3 View Post
    BGI is not a research institute. It is a company that does some research...
    I think BGI is a complicated entity.

    In addition to its business arm, part of it is also a shi-ye-dan-wei


    which is similar to a non-profit org.

    I think by acquiring CG, they gain the know-hows of making a sequencer. I think it is likely they will eventually build a sequencer of their own.

    Comment


    • #17
      Originally posted by ymc View Post
      I think BGI is a complicated entity.

      In addition to its business arm, part of it is also a shi-ye-dan-wei


      which is similar to a non-profit org.

      I think by acquiring CG, they gain the know-hows of making a sequencer. I think it is likely they will eventually build a sequencer of their own.
      If it walks like a duck, quacks like a duck, has feathers like a duck...well, you get the idea.

      Comment


      • #18
        Originally posted by lh3 View Post
        BGI is not a research institute. It is a company that does some research...
        lh3, your description is so concise
        Marco

        Comment


        • #19
          Originally posted by adaptivegenome View Post
          Now BGI gets their US front... And CG is sparred a slow and painful demise...
          not good for everyone ...
          Marco

          Comment


          • #20
            BGI and Gates Foundation Collaborate

            BGI and Gates Foundation Collaborate

            By Bio-IT World Staff

            September 25, 2012 | BGI and the Bill & Melinda Gates Foundation have signed a Memorandum of Understanding (MOU) to begin immediate collaboration on global health and agricultural development.

            “BGI greatly welcomes this opportunity to partner with the Bill & Melinda Gates Foundation to bring the benefit of genomics research to our global society,” said Dr. Huanming Yang, Chairman and Co-Founder of BGI. “We are confident that the combination of our respective capabilities, expertise and experience will yield important scientific breakthroughs in the areas of human, plant and animal genomics that will contribute to the advancement of sustainable health and agriculture development, especially in the developing world.”

            BGI and the Gates Foundation will collaborate on both a strategic level and a specific project level to meaningfully contribute to the achievement of one or more of the United Nations’ Millennium Development Goals. A management committee will be established that will support identification and implementation of collaborations on global health and agricultural development projects.

            Collaboration on specific projects will leverage the Gates Foundation’s agriculture and global health program knowledge and networks with BGI’s sequencing and genomics capabilities to achieve the goal of significantly reducing poverty and/or improving health outcomes in the developing world.

            Strategic objectives include identifying a program of work and collaboration across global health and agricultural development and to conduct work together on initial projects with near-term potential to further develop the working relationship between BGI and the Gates Foundation.

            The agreement supports the prompt and broad dissemination of information from collaboration projects. It also supports broad access to any technology arising from a project. These technologies will be required to be made available at a reasonable cost to the poor.

            "We work closely with partners like BGI to enable breakthroughs in science that will prevent disease and improve agriculture so that farm families can become self-sufficient, reducing hunger and poverty,” said Dr. Trevor Mundel, president of the Global Health Program at the Bill & Melinda Gates Foundation.
            FullGenomes Kit 045DV YFull Terminal SNP Y2846 FTDNA Kit 52277 M35>V12>CTS693>CTS3346>Y2877>CTS6667>CTS8411>Y2846 MTdna U4b1a3a

            Comment


            • #21
              I wonder what exactly they are buying. Is it the machine, ready to go orders, IP clout? I am guessing they are more interested in the ready to go orders, that they can probably churn out at a premium.

              Comment


              • #22
                ... Fast forward 2 years ...

                Is the complete genomics whole genome service still available?
                What is the status of CGI products?

                Was BGI able to salvage anything from this? Or just some patents and the sales force?

                Comment


                • #23
                  Originally posted by Richard Finney View Post
                  ... Fast forward 2 years ...

                  Is the complete genomics whole genome service still available?
                  What is the status of CGI products?

                  Was BGI able to salvage anything from this? Or just some patents and the sales force?
                  They turned CG's machine into BGISEQ-1000.

                  This machine is approved by Chinese Government for clinical use. This is similar to getting FDA 501(k) in the US.

                  The related reagent is approved for NIPT use. I think they are using it to do NIPTs in Chinese hospitals now.

                  Comment

                  Latest Articles

                  Collapse

                  • seqadmin
                    Techniques and Challenges in Conservation Genomics
                    by seqadmin



                    The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.

                    Avian Conservation
                    Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...
                    03-08-2024, 10:41 AM
                  • seqadmin
                    The Impact of AI in Genomic Medicine
                    by seqadmin



                    Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into...
                    02-26-2024, 02:07 PM

                  ad_right_rmr

                  Collapse

                  News

                  Collapse

                  Topics Statistics Last Post
                  Started by seqadmin, 03-14-2024, 06:13 AM
                  0 responses
                  34 views
                  0 likes
                  Last Post seqadmin  
                  Started by seqadmin, 03-08-2024, 08:03 AM
                  0 responses
                  72 views
                  0 likes
                  Last Post seqadmin  
                  Started by seqadmin, 03-07-2024, 08:13 AM
                  0 responses
                  82 views
                  0 likes
                  Last Post seqadmin  
                  Started by seqadmin, 03-06-2024, 09:51 AM
                  0 responses
                  68 views
                  0 likes
                  Last Post seqadmin  
                  Working...
                  X